BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 27622916)

  • 1. Cystic Fibrosis-Related Diabetes in Children: An Update.
    Kim RJ
    Pediatr Ann; 2016 Sep; 45(9):e321-6. PubMed ID: 27622916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Value of continuous glucose monitoring in screening for diabetes in cystic fibrosis].
    Khammar A; Stremler N; Dubus JC; Gross G; Sarles J; Reynaud R
    Arch Pediatr; 2009 Dec; 16(12):1540-6. PubMed ID: 19854630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The course of glucose intolerance in children with cystic fibrosis: a retrospective study - preliminary report.
    Piechowiak K; Trippenbach-Dulska H; Walicka-Serzysko K
    Dev Period Med; 2015; 19(1):80-91. PubMed ID: 26003073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological management of cystic fibrosis related diabetes.
    Moheet A; Moran A
    Expert Rev Clin Pharmacol; 2018 Feb; 11(2):185-191. PubMed ID: 29268054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucose intolerance in cystic fibrosis patients.
    Lanng S
    Paediatr Respir Rev; 2001 Sep; 2(3):253-9. PubMed ID: 12052327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous glucose monitoring and advanced glycation endproducts for prediction of clinical outcomes and development of cystic fibrosis-related diabetes in adults with CF.
    Scully KJ; Brenner L; Martin K; Ruazol M; Sawicki GS; Uluer A; Neuringer I; Yonker LM; Sicilian L; Putman MS
    Front Endocrinol (Lausanne); 2024; 15():1293709. PubMed ID: 38379863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cystic fibrosis related diabetes mellitus - diagnostic and management challenges.
    Lek N; Acerini CL
    Curr Diabetes Rev; 2010 Jan; 6(1):9-16. PubMed ID: 20034372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetes in cystic fibrosis.
    Bridges N
    Paediatr Respir Rev; 2013 May; 14 Suppl 1():16-8. PubMed ID: 23522600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitivity and specificity of different methods for cystic fibrosis-related diabetes screening: is the oral glucose tolerance test still the standard?
    Mainguy C; Bellon G; Delaup V; Ginoux T; Kassai-Koupai B; Mazur S; Rabilloud M; Remontet L; Reix P
    J Pediatr Endocrinol Metab; 2017 Jan; 30(1):27-35. PubMed ID: 27977404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology of cystic fibrosis-related diabetes.
    Marshall BC; Butler SM; Stoddard M; Moran AM; Liou TG; Morgan WJ
    J Pediatr; 2005 May; 146(5):681-7. PubMed ID: 15870674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cystic fibrosis related diabetes: Pathophysiology, screening and diagnosis.
    Granados A; Chan CL; Ode KL; Moheet A; Moran A; Holl R
    J Cyst Fibros; 2019 Oct; 18 Suppl 2():S3-S9. PubMed ID: 31679726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosing cystic fibrosis-related diabetes: current methods and challenges.
    Prentice B; Hameed S; Verge CF; Ooi CY; Jaffe A; Widger J
    Expert Rev Respir Med; 2016 Jul; 10(7):799-811. PubMed ID: 27268400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cystic fibrosis related diabetes.
    Zirbes J; Milla CE
    Paediatr Respir Rev; 2009 Sep; 10(3):118-23; quiz 123. PubMed ID: 19651382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving screening for diabetes in cystic fibrosis.
    Abdulhamid I; Guglani L; Bouren J; Moltz KC
    Int J Health Care Qual Assur; 2015; 28(5):441-51. PubMed ID: 26020427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Canadian Cystic Fibrosis-related Diabetes Clinical Practice Survey: Analysis of Current Practices and Gaps in Clinical Care.
    Potter KJ; Coriati A; Hicks P; Lands LC; McKinney ML; Boudreau V; Bonhoure A; Luca P; Ho J; Tagougui S; Jober A; Pohl M; Rosolowsky ET; Gilmour J; Lam GY; Stephenson AL; Senior PA; Rabasa-Lhoret R; Kherani T
    Can J Diabetes; 2023 Apr; 47(3):263-271.e1. PubMed ID: 36872137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cystic-fibrosis related-diabetes (CFRD) is preceded by and associated with growth failure and deteriorating lung function.
    Terliesner N; Vogel M; Steighardt A; Gausche R; Henn C; Hentschel J; Kapellen T; Klamt S; Gebhardt J; Kiess W; Prenzel F
    J Pediatr Endocrinol Metab; 2017 Aug; 30(8):815-821. PubMed ID: 28245190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucose >200 mg/dL during Continuous Glucose Monitoring Identifies Adult Patients at Risk for Development of Cystic Fibrosis Related Diabetes.
    Taylor-Cousar JL; Janssen JS; Wilson A; Clair CG; Pickard KM; Jones MC; Brayshaw SJ; Chacon CS; Barboa CM; Sontag MK; Accurso FJ; Nichols DP; Saavedra MT; Nick JA
    J Diabetes Res; 2016; 2016():1527932. PubMed ID: 27999822
    [No Abstract]   [Full Text] [Related]  

  • 18. Peak OGTT glucose is associated with lower lung function in young children with cystic fibrosis.
    Prentice BJ; Chelliah A; Ooi CY; Hameed S; Verge CF; Plush L; Widger J
    J Cyst Fibros; 2020 Mar; 19(2):305-309. PubMed ID: 31126898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cystic fibrosis related diabetes (CFRD)--the end stage of progressive insulin deficiency.
    Hameed S; Jaffé A; Verge CF
    Pediatr Pulmonol; 2011 Aug; 46(8):747-60. PubMed ID: 21626717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycated hemoglobin cannot yet be proposed as a screening tool for cystic fibrosis related diabetes.
    Boudreau V; Coriati A; Desjardins K; Rabasa-Lhoret R
    J Cyst Fibros; 2016 Mar; 15(2):258-60. PubMed ID: 26905501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.